APA (7th ed.) Citation

Li, K., Chen, J., Hu, Y., Wang, Y., Shen, Y., Chen, G., . . . Sun, C. (2024). Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): A multicentre, single-arm, phase 2 trial. The lancet oncology, 25(1), 76-85. https://doi.org/10.1016/S1470-2045(23)00531-4

Chicago Style (17th ed.) Citation

Li, Kezhen, et al. "Neoadjuvant Chemotherapy Plus Camrelizumab for Locally Advanced Cervical Cancer (NACI Study): A Multicentre, Single-arm, Phase 2 Trial." The Lancet Oncology 25, no. 1 (2024): 76-85. https://doi.org/10.1016/S1470-2045(23)00531-4.

MLA (9th ed.) Citation

Li, Kezhen, et al. "Neoadjuvant Chemotherapy Plus Camrelizumab for Locally Advanced Cervical Cancer (NACI Study): A Multicentre, Single-arm, Phase 2 Trial." The Lancet Oncology, vol. 25, no. 1, 2024, pp. 76-85, https://doi.org/10.1016/S1470-2045(23)00531-4.